Sherpa in Targeted Cancer Therapies and Brain Tech
14 Oct 2026
US$ 20.00
Sherpa Healthcare Partners has led the over Rmb300 m (US$44.8 m) series A funding round of Allygen Biologics ......
Related Publications
Subscribers’ Weekly for the week ending 16 Oct 2026...
International Finance Corp has proposed to allocate up to US$25 m to Eversource Partners II-2 LP, a feeder fund that ......
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.